Cita APA (7a ed.)

Wang, J., Huang, T., Chang, P., Chen, Y., Chang, C., Chen, F., . . . Chen, Y. (2018). Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization. Nature Portfolio.

Cita Chicago Style (17a ed.)

Wang, Jia-Kang, Tzu-Lun Huang, Pei-Yao Chang, Yen-Ting Chen, Chin-Wei Chang, Fang-Ting Chen, Yung-Ray Hsu, y Yun-Ju Chen. Intravitreal Aflibercept Versus Bevacizumab for Treatment of Myopic Choroidal Neovascularization. Nature Portfolio, 2018.

Cita MLA (8a ed.)

Wang, Jia-Kang, et al. Intravitreal Aflibercept Versus Bevacizumab for Treatment of Myopic Choroidal Neovascularization. Nature Portfolio, 2018.